Skip to main content
. 2021 Aug 13;8:691641. doi: 10.3389/fcvm.2021.691641

Table 3.

Risk of various clinical outcomes up to 5 years in all patients.

Outcomes Incidence of event at 5 years [ n (%)] Crude HR (95% CI) P-value Adjusted HR (95% CI) P-value
Diabetes (n = 316) Non-diabetes (n = 403)
All-cause mortality 16 (5.1) 7 (1.7) 2.97 (1.22–7.23) 0.016 2.37 (0.94–5.98) 0.068
Cardiac death 7 (2.2) 4 (1.0) 2.26 (0.66–7.73) 0.192 1.17 (0.30–4.60) 0.822
MI 23 (7.3) 32 (7.9) 0.93 (0.54–1.59) 0.790 0.91 (0.52–1.59) 0.744
Stroke 11 (3.5) 11 (2.7) 1.30 (0.56–2.99) 0.541 1.00 (0.43–2.35) 1.000
TVR 64 (20.3) 67 (16.6) 1.25 (0.89–1.76) 0.204 1.28 (0.90–1.81) 0.169
MACCE 90 (28.5) 85 (21.1) 1.40 (1.04–1.88) 0.028 1.47 (1.08–2.00) 0.013

MI, myocardial infarction; TVR, target-vessel revascularization; MACCE, major adverse cardiac and cerebrovascular events.